The health crisis has particularly hit the response to TB and led countries to fall behind in meeting targets to curb the infectious disease. Merck lifts full-year forecast as Keytruda sales soar Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on a jump in demand for blockbuster cancer immunotherapy Keytruda and human papillomavirus vaccine Gardasil.